Developer docs
API playgroundTry for free, no card

Search company profiles

Xebios Diagnostics Group

Full company profile

uuid000cxty

Namestring
Xebios Diagnostics Group
Legal namestring
Solabia Xebios GmbH
Websiteurl
xebios.de
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Xebios Diagnostics Group (now operating as Solabia Xebios GmbH) is a German-domiciled manufacturer of ready-to-use culture media and test reagents for microbiological diagnostics, headquartered in Düsseldorf with additional production sites in Eindhoven and Groningen, the Netherlands. The company produces Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), including selective enrichment broths, chromogenic agars, and specialized reagents for detecting pathogens such as Legionella, E. coli, coliforms, Salmonella, Listeria, and S. aureus. Supporting offerings include dehydrated culture media, the Xebios-App (a mobile and web tool for certificate management, inventory tracking, and QR-code-based product information), TCS Selectrol quality control reference organisms, Sartorius Microsart membrane filtration products distributed as a channel partner, and the COLIKAT RAPID 18-hour rapid test for E. coli/coliform enumeration per DIN EN ISO 9308-2.

The business serves B2B customers across five vertical segments: water testing laboratories (drinking water, mineral water, wastewater), food and beverage manufacturers, cosmetics manufacturers, pharmaceutical manufacturers (GMP compliance, environmental monitoring), and clinical/medical laboratories. Quality control is conducted in conformity with ISO 11133 and Ph. Eur., and customer-specific certificates are provided to reduce or eliminate incoming inspection burden. Differentiated logistics include company-owned delivery vehicles, Just-In-Time delivery, batch reservation, reusable container systems, and shelf service to customer laboratories.

Revenue is generated through direct, sales-led B2B distribution via account managers, website inquiry forms, and online catalog — no public pricing is disclosed. The go-to-market emphasizes a "system partner" positioning that bundles products, QC services, the Xebios-App, and proprietary logistics. In March 2026, Solabia Group (a Paris-headquartered biotechnology platform backed by private equity investor Astorg) announced the acquisition of Xebios Diagnostics Group, integrating it under Solabia Xebios GmbH and combining production capabilities across France, Germany, and the Netherlands. Post-acquisition, the entity is led by Managing Directors Stephane Laugier and Francois Pointurier.

Short descriptiontext

Xebios Diagnostics Group (now Solabia Xebios GmbH) manufactures ready-to-use culture media and test reagents for microbiological diagnostics, serving water, food, beverage, cosmetics, pharma, and clinical laboratories across Germany and the Netherlands.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDüsseldorf, Germany
HQ citystring
Düsseldorf
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiological diagnostics, ready-to-use culture media, test reagents, water microbiology testing, food microbiology testing
Industry5 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAC
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYAFALAEAK
Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYAFALAKAF
Microbiological Reference Cultures, Strains & Controls (Food Micro)
Agriculture & Food Production/Food Safety, Testing & Certification/Laboratory Proficiency Testing, Method Validation & Reference Materials (Food)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Microbiological Diagnostics Consumables
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Culture Media and Reagents Sales
TypeOne Time License
Description

Sale of ready-to-use and dehydrated culture media, test reagents, and reference organisms for microbiological testing. Products include selective media for pathogens, chromogenic media for indicator organisms, and QC control strains.

xebios.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Xebios Diagnostics Group manufactures and supplies ready-to-use culture media (Fertignährmedien), dehydrated culture media, and microbiological test reagents used by laboratories in water, food and beverage, cosmetics, pharmaceutical, and clinical diagnostics. The portfolio is complemented by rapid tests such as COLIKAT RAPID, the company's own Xebios-App for product information and ordering, and resold third-party consumables including Sartorius Microsart e.motion filtration products and TCS Selectrol Discs quality control reference organisms.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Xebios Diagnostics Group operates as a system partner for ready-to-use culture media and test reagents for microbiological diagnostics. The company manufactures products for testing drinking water, food, beverages, cosmetics, pharmaceutical products, and clinical samples for bacterial and viral contamination. The core product line consists of Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), which include various agar plates, broths, and selective enrichment media. Supporting offerings include the Xebios-App (mobile application for certificate management and inventory tracking), TCS Selectrol quality control discs, Sartorius Microsart membrane filtration products, COLIKAT RAPID 18-hour rapid test, dehydrated culture media, quality control services (ISO 11133/Ph. Eur. compliant), and proprietary logistics services. The company operates three production sites in Düsseldorf, Eindhoven (Netherlands), and Groningen (Netherlands) and was acquired by Solabia Group in March 2026.

Product and service1 record
1Ready-to-use culture media (Fertignährmedien)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

Solabia Group, a Paris-headquartered biotechnology platform, acquired Xebios Diagnostics Group in March 2026. The acquisition strengthens Solabia's European diagnostics footprint, enhances manufacturing capabilities across France, Germany, and the Netherlands, and provides complementary product portfolios and geographic reach.

2Mibelle Biochemistry
Strategic tierMinorTypeOthers
Description

Part of Solabia's three strategic acquisitions announced in March 2026, alongside Seqens' Botanical Actives and In-Vitro Diagnostics activity. Mibelle Biochemistry is Switzerland-based.

xebios.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in industrial and clinical microbiology, including culture media, reagents, and automated identification/AST platforms. Directly comparable as a manufacturer of ready-to-use culture media and microbiological diagnostic reagents serving the same water, food, pharma, and clinical end-markets, though at significantly larger scale with bundled instrument solutions.

2Merck KGaA / MilliporeSigma
TypeDirect peer
Description

Sells an extensive portfolio of dehydrated and ready-to-use culture media, chromogenic media, and QC reference organisms under the MilliporeSigma brand. Overlaps with Xebios across all five verticals and competes on catalog breadth, regulatory documentation, and global distribution reach.

TypeBroad incumbent
Description

Through its Microbiology and Microbiological Sciences business, offers culture media, prepared media, and diagnostic reagents alongside instruments and consumables. Comparable as a broad incumbent offering overlapping product categories, with greater scale, global reach, and bundled automation capabilities.

TypeBroad incumbent
Description

Manufactures BD Prepared Culture Media and BD MAX molecular diagnostics, with a strong clinical microbiology franchise. Competes with Xebios in clinical microbiology culture media and reagent consumables, particularly in hospital laboratories.

TypeDirect peer
Description

Provides membrane filtration products (Microsart) that Xebios resells alongside its culture media, and Sartorius also offers biopharmaceutical quality control solutions including microbiological testing. Comparable as a supplier of complementary water-testing and QC consumables.

6HiMedia Laboratories
TypeEmerging player
Description

India-based manufacturer with a broad portfolio of dehydrated and ready-prepared culture media, microbial identification strips, and QC organisms. Comparable as a specialist culture media manufacturer expanding into international markets and competing on price/portfolio breadth.

TypeEmerging player
Description

Italian manufacturer of ready-to-use culture media, antimicrobial susceptibility discs, and microbiological diagnostic kits. Comparable as a European mid-sized specialist with similar product mix and regulatory positioning, often competing in the same tenders for water and clinical labs.

TypeEmerging player
Description

Spanish manufacturer specializing in dehydrated and ready-to-use culture media, chromogenic media, and microbiology reagents. Comparable as a regional European specialist serving food, water, clinical, and pharma laboratories with a similar product-to-service model.

TypeBroad incumbent
Description

Parent company post-March 2026 acquisition; Paris-headquartered biotech platform with broader diagnostics, biotechnology, and life science ingredient capabilities. Relevant as the acquirer and as a portfolio platform covering adjacent microbiology, excipients, and diagnostic ingredients.

TypeBroad incumbent
Description

Global CRO and supplier of microbiological testing products, endotoxin detection, and QC organisms used in pharmaceutical and biopharmaceutical manufacturing. Comparable as a broader player serving Xebios's pharmaceutical and clinical end-markets with overlapping QC consumables and testing services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xebios Diagnostics Group

Microbiological Diagnostics Consumablesxebios.de

Xebios Diagnostics Group (now Solabia Xebios GmbH) manufactures ready-to-use culture media and test reagents for microbiological diagnostics, serving water, food, beverage, cosmetics, pharma, and clinical laboratories across Germany and the Netherlands.

What Xebios Diagnostics Group does

Xebios Diagnostics Group (now operating as Solabia Xebios GmbH) is a German-domiciled manufacturer of ready-to-use culture media and test reagents for microbiological diagnostics, headquartered in Düsseldorf with additional production sites in Eindhoven and Groningen, the Netherlands. The company produces Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), including selective enrichment broths, chromogenic agars, and specialized reagents for detecting pathogens such as Legionella, E. coli, coliforms, Salmonella, Listeria, and S. aureus. Supporting offerings include dehydrated culture media, the Xebios-App (a mobile and web tool for certificate management, inventory tracking, and QR-code-based product information), TCS Selectrol quality control reference organisms, Sartorius Microsart membrane filtration products distributed as a channel partner, and the COLIKAT RAPID 18-hour rapid test for E. coli/coliform enumeration per DIN EN ISO 9308-2.

The business serves B2B customers across five vertical segments: water testing laboratories (drinking water, mineral water, wastewater), food and beverage manufacturers, cosmetics manufacturers, pharmaceutical manufacturers (GMP compliance, environmental monitoring), and clinical/medical laboratories. Quality control is conducted in conformity with ISO 11133 and Ph. Eur., and customer-specific certificates are provided to reduce or eliminate incoming inspection burden. Differentiated logistics include company-owned delivery vehicles, Just-In-Time delivery, batch reservation, reusable container systems, and shelf service to customer laboratories.

Revenue is generated through direct, sales-led B2B distribution via account managers, website inquiry forms, and online catalog — no public pricing is disclosed. The go-to-market emphasizes a "system partner" positioning that bundles products, QC services, the Xebios-App, and proprietary logistics. In March 2026, Solabia Group (a Paris-headquartered biotechnology platform backed by private equity investor Astorg) announced the acquisition of Xebios Diagnostics Group, integrating it under Solabia Xebios GmbH and combining production capabilities across France, Germany, and the Netherlands. Post-acquisition, the entity is led by Managing Directors Stephane Laugier and Francois Pointurier.

Xebios Diagnostics Group firmographics

Firmographics
Name
Xebios Diagnostics Group
Legal name
Solabia Xebios GmbH
Website
https://xebios.de
Company type
Private
Founded year
1989
Operating status
Acquired
Headcount range
11–50 employees
Short description
Xebios Diagnostics Group (now Solabia Xebios GmbH) manufactures ready-to-use culture media and test reagents for microbiological diagnostics, serving water, food, beverage, cosmetics, pharma, and clinical laboratories across Germany and the Netherlands.
Ownership category
akta.pro rank

Xebios Diagnostics Group industry classification

Industry
Product category
Microbiological Diagnostics Consumables
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAC
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYAFALAEAK
Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYAFALAKAF
Microbiological Reference Cultures, Strains & Controls (Food Micro)
Agriculture & Food Production/Food Safety, Testing & Certification/Laboratory Proficiency Testing, Method Validation & Reference Materials (Food)

Keywords

  • Microbiological diagnostics
  • Ready-to-use culture media
  • Test reagents
  • Water microbiology testing
  • Food microbiology testing

Where Xebios Diagnostics Group is headquartered

Location

Headquarters

HQ city
Düsseldorf
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Xebios Diagnostics Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Culture Media and Reagents Sales: Sale of ready-to-use and dehydrated culture media, test reagents, and reference organisms for microbiological testing. Products include selective media for pathogens, chromogenic media for indicator organisms, and QC control strains.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Xebios Diagnostics Group product offering

Product offering

Core offering

Xebios Diagnostics Group manufactures and supplies ready-to-use culture media (Fertignährmedien), dehydrated culture media, and microbiological test reagents used by laboratories in water, food and beverage, cosmetics, pharmaceutical, and clinical diagnostics. The portfolio is complemented by rapid tests such as COLIKAT RAPID, the company's own Xebios-App for product information and ordering, and resold third-party consumables including Sartorius Microsart e.motion filtration products and TCS Selectrol Discs quality control reference organisms.

Product overview

Xebios Diagnostics Group operates as a system partner for ready-to-use culture media and test reagents for microbiological diagnostics. The company manufactures products for testing drinking water, food, beverages, cosmetics, pharmaceutical products, and clinical samples for bacterial and viral contamination. The core product line consists of Fertignährmedien (ready-to-use culture media) and Testreagenzien (test reagents), which include various agar plates, broths, and selective enrichment media. Supporting offerings include the Xebios-App (mobile application for certificate management and inventory tracking), TCS Selectrol quality control discs, Sartorius Microsart membrane filtration products, COLIKAT RAPID 18-hour rapid test, dehydrated culture media, quality control services (ISO 11133/Ph. Eur. compliant), and proprietary logistics services. The company operates three production sites in Düsseldorf, Eindhoven (Netherlands), and Groningen (Netherlands) and was acquired by Solabia Group in March 2026.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ready-to-use culture media (Fertignährmedien)

Companies that use Xebios Diagnostics Group

Customer profile

Segments5 records

Ideal customer profiles1 record

Xebios Diagnostics Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Xebios Diagnostics Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Solabia GroupcoreOthersSolabia Group, a Paris-headquartered biotechnology platform, acquired Xebios Diagnostics Group in March 2026. The acquisition strengthens Solabia's European diagnostics footprint, enhances manufacturing capabilities across France, Germany, and the Netherlands, and provides complementary product portfolios and geographic reach.
  • Mibelle BiochemistryminorOthersPart of Solabia's three strategic acquisitions announced in March 2026, alongside Seqens' Botanical Actives and In-Vitro Diagnostics activity. Mibelle Biochemistry is Switzerland-based.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Xebios Diagnostics Group competitors and assessment

Company assessment

Direct peers

  • bioMérieux: Global leader in industrial and clinical microbiology, including culture media, reagents, and automated identification/AST platforms. Directly comparable as a manufacturer of ready-to-use culture media and microbiological diagnostic reagents serving the same water, food, pharma, and clinical end-markets, though at significantly larger scale with bundled instrument solutions.
  • Merck KGaA / MilliporeSigma: Sells an extensive portfolio of dehydrated and ready-to-use culture media, chromogenic media, and QC reference organisms under the MilliporeSigma brand. Overlaps with Xebios across all five verticals and competes on catalog breadth, regulatory documentation, and global distribution reach.
  • Sartorius: Provides membrane filtration products (Microsart) that Xebios resells alongside its culture media, and Sartorius also offers biopharmaceutical quality control solutions including microbiological testing. Comparable as a supplier of complementary water-testing and QC consumables.

Broad incumbents

  • Thermo Fisher Scientific: Through its Microbiology and Microbiological Sciences business, offers culture media, prepared media, and diagnostic reagents alongside instruments and consumables. Comparable as a broad incumbent offering overlapping product categories, with greater scale, global reach, and bundled automation capabilities.
  • BD (Becton Dickinson): Manufactures BD Prepared Culture Media and BD MAX molecular diagnostics, with a strong clinical microbiology franchise. Competes with Xebios in clinical microbiology culture media and reagent consumables, particularly in hospital laboratories.
  • Solabia Group: Parent company post-March 2026 acquisition; Paris-headquartered biotech platform with broader diagnostics, biotechnology, and life science ingredient capabilities. Relevant as the acquirer and as a portfolio platform covering adjacent microbiology, excipients, and diagnostic ingredients.
  • Charles River Laboratories: Global CRO and supplier of microbiological testing products, endotoxin detection, and QC organisms used in pharmaceutical and biopharmaceutical manufacturing. Comparable as a broader player serving Xebios's pharmaceutical and clinical end-markets with overlapping QC consumables and testing services.

Emerging players

  • HiMedia Laboratories: India-based manufacturer with a broad portfolio of dehydrated and ready-prepared culture media, microbial identification strips, and QC organisms. Comparable as a specialist culture media manufacturer expanding into international markets and competing on price/portfolio breadth.
  • Liofilchem: Italian manufacturer of ready-to-use culture media, antimicrobial susceptibility discs, and microbiological diagnostic kits. Comparable as a European mid-sized specialist with similar product mix and regulatory positioning, often competing in the same tenders for water and clinical labs.
  • Condalab: Spanish manufacturer specializing in dehydrated and ready-to-use culture media, chromogenic media, and microbiology reagents. Comparable as a regional European specialist serving food, water, clinical, and pharma laboratories with a similar product-to-service model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Xebios Diagnostics Group social profiles

Digital presence

Xebios Diagnostics Group compliance and trust

Trust signal

Compliance1 record

Xebios Diagnostics Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xebios Diagnostics Group leadership team

Management profile

Number of profiles

Profiles3 records

Xebios Diagnostics Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xebios Diagnostics Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xebios Diagnostics Group

What does Xebios Diagnostics Group do?

Xebios Diagnostics Group manufactures and supplies ready-to-use culture media (Fertignährmedien), dehydrated culture media, and microbiological test reagents used by laboratories in water, food and beverage, cosmetics, pharmaceutical, and clinical diagnostics. The portfolio is complemented by rapid tests such as COLIKAT RAPID, the company's own Xebios-App for product information and ordering, and resold third-party consumables including Sartorius Microsart e.motion filtration products and TCS Selectrol Discs quality control reference organisms.

Is Xebios Diagnostics Group a public or private company?

Xebios Diagnostics Group is a private company. It is classified as corporate owned and is currently acquired.

When was Xebios Diagnostics Group founded?

Xebios Diagnostics Group was founded in 1989. It employs 11 to 50 people.

Where is Xebios Diagnostics Group based?

Xebios Diagnostics Group is headquartered in Düsseldorf, Germany, in the Europe region.

How does Xebios Diagnostics Group make money?

One revenue line is on record: culture Media and Reagents Sales.

Who are Xebios Diagnostics Group's main competitors?

Direct peers on record are bioMérieux, Merck KGaA / MilliporeSigma and Sartorius. Broad incumbents are Thermo Fisher Scientific, BD (Becton Dickinson), Solabia Group and Charles River Laboratories. Emerging players are HiMedia Laboratories, Liofilchem and Condalab.

Does Xebios Diagnostics Group have an API?

No public API is recorded for Xebios Diagnostics Group.

What industry is Xebios Diagnostics Group in?

Xebios Diagnostics Group's product category is Microbiological Diagnostics Consumables. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SolabiaXebios Diagnostics joins Solabia GroupSolabia announced the acquisition of Xebios Diagnostics Group, a leading microbiological diagnostics solution provider with operations in Germany and the Netherlands. Xebios specializes in diagnostic culture media and reagents for water, food, beverages, cosmetics, and clinical samples, operating three production sites and serving customers across the German and Benelux markets. The combination strengthens Solabia's manufacturing base across France, Germany, and the Netherlands while enhancing its innovation capacity and geographic reach in the European diagnostics market.Pulse 2.0Solabia: Biotechnology Platform Expands With Three Strategic AcquisitionsSolabia, a Paris-headquartered biotechnology platform, has agreed to acquire three complementary businesses — Switzerland-based Mibelle Biochemistry, Seqens' Botanical Actives and In-Vitro Diagnostics activity in France, and Xebios Group operating across Germany and the Netherlands — as part of its international expansion strategy backed by investor Astorg. The combined acquisitions broaden Solabia's capabilities in natural active ingredients for cosmetics and advanced diagnostics solutions while strengthening its European footprint and supply chain. This marks a significant step in Solabia's evolution into a scaled, independent biotechnology platform serving customers worldwide across cosmetics, nutraceutical, pharmaceutical, food, and clinical testing industries.